Recent studies demonstrated Thr315Ile and Phe317Leu occupied (5/37, 14%) mutations in the gatekeeper region of BCR-ABL gene in CML patients11. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.